AmeriCann’s Massachusetts Cannabis Center Featured on CNN Special Report
AmeriCann’s Massachusetts Cannabis Center Featured on CNN Special Report
Dr. Sanjay Gupta's Award-winning Series WEED 6: Marijuana and Autism Will Broadcast Again on Friday, Dec. 24 at 6 P.M. EST
Sanjay Gupta博士的获奖系列《大麻6：大麻和自闭症》将于12月24日(星期五)美国东部时间下午6点再次播出。
BOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AmeriCann Inc. (OTCQB:ACAN) (the "Company"), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, announced that the Company's Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments for autism.
波士顿，2021年12月22日(环球通讯社)--Via InvestorWire--americann Inc.(场外交易市场代码：ACAN)是一家开发最先进种植、产品制造和分销设施的大麻公司(以下简称“公司”)，该公司宣布，该公司的马萨诸塞州大麻中心出现在桑杰·古普塔(Sanjay Gupta)博士在CNN节目中探索自闭症大麻疗法的获奖系列节目中。
"For nearly a decade Dr. Sanjay Gupta's breakthrough series has shattered myths and introduced the healing properties of cannabis on a global stage," stated AmeriCann CEO Tim Keogh. "We are proud to play a role in helping Dr. Gupta present the considerable benefits that severe autism patients have achieved being treated with cannabis."
“近十年来，桑贾伊·古普塔博士的突破性系列打破了神话，并在全球舞台上介绍了大麻的治疗作用，”americann首席执行官蒂姆·基奥(Tim Keogh)说。我们为能在帮助古普塔博士展示严重自闭症患者接受大麻治疗所获得的巨大好处方面发挥作用而感到自豪。“
AmeriCann hosted the CNN film crew earlier this year in Building 1 of the Company's flagship project, the Massachusetts Cannabis Center.
今年早些时候，American ann在该公司旗舰项目马萨诸塞州大麻中心(Massachusetts Cannabis Center)的1号楼接待了CNN摄制组。
AmeriCann's Massachusetts Cannabis Center is located on a 52-acre parcel in southeastern Massachusetts. The project is permitted for 987,000 square feet of cannabis cultivation and processing infrastructure, which is being developed in phases, and will support multiple tenants in both the existing medical and adult-use cannabis markets.
美国人的马萨诸塞州大麻中心位于马萨诸塞州东南部一块占地52英亩的地块上。该项目允许提供98.7万平方英尺的大麻种植和加工基础设施，该基础设施正在分阶段开发，并将支持现有医用和成人用大麻市场的多个租户。
The initial phase of the development, Building 1, is a fully operational 30,000-square-foot cultivation greenhouse and processing facility that utilizes AmeriCann's proprietary "Cannopy" cultivation system.
开发的第一阶段，1号楼，是一个完全投入使用的3万平方英尺的栽培温室和加工设施，利用americann专有的“Cannopy”种植系统。
AmeriCann recently released a video highlighting the high-tech, sustainable designs at the Massachusetts Cannabis Center and Building 1 which can be found HERE.
美国人最近发布了一段视频，重点介绍了马萨诸塞州大麻中心和1号楼的高科技、可持续设计，这些设计可以在这里找到。
About AmeriCann
AmeriCann (OTCQB:ACAN) develops and leases cannabis cultivation, processing and product manufacturing facilities.
关于美国人
Americann(场外交易市场代码：ACAN)开发和租赁大麻种植、加工和产品制造设施。
AmeriCann uses greenhouse technology which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25 percent fewer lights, and utility bills are up to 75 percent less than in typical warehouse cultivation facilities. As such, AmeriCann's Cannopy System enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs.
美国人使用的温室技术优于目前的行业标准，即在人造灯光下在仓库设施中种植大麻。根据行业专家的说法，通过捕捉自然阳光，温室使用的灯光减少了25%，公用事业账单比典型的仓库种植设施减少了75%。因此，americann的Cannopy系统使大麻的生产大大减少了碳足迹，从而降低了最终产品的成本。此外，温室建设成本几乎占仓库建设成本的一半。
AmeriCann is also designing GMP Certified cannabis extraction and product manufacturing infrastructure. The Company has secured licenses to produce cannabis infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center.
美国人还在设计GMP认证的大麻提取和产品制造基础设施。该公司已经获得了生产注入大麻的产品的许可证，包括饮料、食品、外用药物和浓缩物。Americann计划在马萨诸塞州大麻中心经营一家大麻产品制造企业。
Forward-Looking Statements
前瞻性陈述
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company's forward-looking statements, please see the Company's Registration Statement on Form S-1 which may be viewed at www.sec.gov.
本新闻稿包含修订后的1933年证券法第27A节和修订后的1934年证券交易法(“交易法”)第21E节所指的“前瞻性陈述”(这两节被采纳为1995年私人证券诉讼改革法的一部分)。在“相信”、“预期”、“估计”、“预期”、“打算”、“计划”、“项目”、“展望”、“展望”以及类似的词语或表达，或未来或条件动词，如“将”、“应该”、“将”、“可能”和“可能”等词语之前、之后或以其他方式包括“相信”、“预期”、“估计”、“预期”、“打算”、“计划”、“项目”、“展望”和“展望”等词语的陈述，一般都是前瞻性的，而不是历史事实。这些前瞻性陈述涉及已知和未知的风险、不确定因素和其他因素，这些风险、不确定因素和其他因素可能导致公司的实际结果、业绩或成就与任何预期的结果、业绩或成就大不相同。无论是由于新信息、未来事件或其他原因，公司没有任何修改任何前瞻性陈述的意图，也没有义务修改任何前瞻性陈述。有关可能影响公司前瞻性陈述的其他不确定因素，请参阅公司S-1表格中的注册声明，该声明可在www.sec.gov上查看。
Contact Information:
Corporate:
info@americann.co
@ACANinfo on Twitter
@AmeriCann on Facebook
@AmeriCannInc on Instagram
联系方式：
公司：
邮箱：info@americann.co
@Twitter上的ACANinfo
@Facebook上的@americann
@ameriCannInc.在Instagram上
Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com
企业通信
IBN(InvestorBrandNetwork)
加利福尼亚州洛杉矶
310.299.1717办事处
电子邮箱：Editor@InvestorBrandNetwork.com